Listings on the PBS for Aboriginal and Torres Strait Islander people

The Australian Government is committed to improving the capability of the Pharmaceutical Benefits Scheme (PBS) to better meet the needs of Aboriginal and Torres Strait Islander people. The Pharmaceutical Benefits Advisory Committee is assisting this goal by evaluating and recommending the listing of medications specifically to help with the health needs of Aboriginal and Torres Strait Islander people.

This list details all PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people. For more information about PBS access by Aboriginal and Torres Strait Islander people, see Improving the capacity of the PBS to meet particular Aboriginal and Torres Strait Islander health needs in the explanatory notes, or contact us at pbs-indigenous@health.gov.au.

 

Authority required (STREAMLINED)

3136 Nasal colonisation with Staphylococcus aureus in an Aboriginal or a Torres Strait Islander person.

Note:
No applications for increased maximum quantities and/or repeats will be authorised.

9440W Mupirocin, Nasal ointment 20 mg (as calcium) per g (2%), 3 g (Bactroban)

 

Authority required

Nicotine dependence in an Aboriginal or a Torres Strait Islander person as the sole PBS-subsidised therapy.

Note:
Only 2 courses of PBS-subsidised nicotine replacement therapy will be authorised per year.
No applications for increased maximum quantities and/or repeats will be authorised.
Benefit is improved if used in conjunction with a comprehensive support and counselling program.

9198D Nicotine, Transdermal patch releasing approximately 15 mg per 16 hours (Nicorette Patch)

5465P Nicotine, Transdermal patch releasing approximately 21 mg per 24 hours (Nicabate P)

5571F Nicotine, Transdermal patch releasing approximately 21 mg per 24 hours (Nicotinell Step 1)

 

Authority required

Treatment of a dermatophyte infection in an Aboriginal or a Torres Strait Islander person where topical treatment has failed;

2285G Terbinafine, Tablet 250 mg (as hydrochloride) (Lamisil, GenRx Terbinafine, Sebifin 250, Tamsil, Terbihexal, Terbinafine-DRLA, Terbinafine-GA, Terbinafine 250, Terbix 250, Tinasil)

 

Authority required (STREAMLINED)

2354 Treatment of a fungal or a yeast infection in an Aboriginal or a Torres Strait Islander person.

9024Y Ketoconazole, Cream 20 mg per g (2%), 30 g (Nizoral 2% Cream)

9025B Ketoconazole, Shampoo 10 mg per g (1%), 100 mL (Nizoral 1%)

1574W Ketoconazole, Shampoo 20 mg per g (2%), 60 mL (Nizoral 2%)

9026C Miconazole nitrate, Cream 20 mg per g (2%), 15 g (Daktarin)

9027D Miconazole nitrate, Cream 20 mg per g (2%), 30 g (Daktarin)

9028E Miconazole nitrate, Cream 20 mg per g (2%), 70 g (Daktarin)

9029F Miconazole nitrate, Powder 20 mg per g (2%), 30 g (Daktarin)

9030G Miconazole nitrate, Lotion 20 mg per mL (2%), 30 g (Daktarin)

9031H Miconazole, Tincture 20 mg per mL (2%), 30 mL (Daktarin)

1698J Nystatin, Cream 100,000 units per g, 15 g  (Mycostatin)

9160D Terbinafine, Cream containing terbinafine hydrochloride 10 mg per g (1%), 15 g (Lamisil)

 

Authority required (STREAMLINED)

2384 Prophylaxis of thiamine deficiency in an Aboriginal or a Torres Strait Islander person

1070H Thiamine hydrochloride, Tablet 100 mg (Betamin)

 

Authority required (STREAMLINED) (additional indications added 1 March 2010)

2446 Treatment of whipworm infestation in an Aboriginal or Torres Strait Islander person;

1388 Strongyloidiasis;

3241 Treatment of hookworm infestation.

9047E Albendazole, Tablet 200 mg (Zentel)

 

Authority required

Treatment of chronic suppurative otitis media in an Aboriginal or a Torres Strait Islander person aged 1 month and over.

2480M Ciprofloxacin, Ear drops 3 mg per mL (0.3%), 5 mL (Ciloxan)

 

Authority Required

Hypomagnesaemia in an Aboriginal or a Torres Strait Islander person;
Chronic renal disease in an Aboriginal or a Torres Strait Islander person.

5146W Magnesium, Tablet 37.4 mg (as aspartate dihydrate) (Mag-Sup)

 

Last Updated: 16 February 2012